Home    Back

Liposomal bupivacaine    (DrugBank: Bupivacaine)

3 diseases
IDDisease name (Link within this page)Number of trials
51Scleroderma1
70Spinal stenosis2
96Crohn disease1

51. Scleroderma    [ 466 clinical trials,   536 drugs,   (DrugBank: 142 drugs),   110 drug target genes,   210 drug target pathways]
Searched query = "Scleroderma", "Systemic sclerosis", "SSc", "dcSSc", "lcSSc"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 466 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT02374320
(ClinicalTrials.gov)		November 201423/2/2015Exparel as a Nerve Block for Severe Hand PainChemical Sympathectomy Following Peripheral Nerve Block With Liposomal BupivacaineCREST Syndrome;Peripheral Vascular Disease;Raynaud Disease;Scleroderma, DiffuseDrug: liposomal bupivacaineJose Soberon, MDNULLTerminated18 YearsN/AAll14Phase 2;Phase 3United States

70. Spinal stenosis    [ 91 clinical trials,   195 drugs,   (DrugBank: 54 drugs),   60 drug target genes,   85 drug target pathways]
Searched query = "Spinal stenosis", "Extensive spinal canal stenosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 91 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04066296
(ClinicalTrials.gov)		September 20203/7/2019Outcomes for Lumbar Decompressions With Use of Liposomal BupivicaineA Double Blinded Randomized Control Trial in Outcomes for Lumbar Decompressions With Use of Liposomal BupivicaineLumbar Spinal StenosisDrug: Liposomal bupivacaineUniversity of Colorado, DenverNULLNot yet recruiting18 YearsN/AAll100Phase 2NULL
2NCT03745040
(ClinicalTrials.gov)		January 26, 20195/11/2018Liposomal Bupivacaine in One-level Instrumented Posterior Spinal FusionDoes Liposomal Bupivacaine Improve Postoperative Pain Control After One Level Posterior Spinal Fusion With InstrumentationLumbar Spinal Stenosis;Lumbar Disc Herniation;Lumbar Disc Disease;Lumbar SpondylolisthesisDrug: Liposomal bupivacaineAllina Health SystemTwin Cities Spine CenterRecruiting18 YearsN/AAll60Phase 4United States

96. Crohn disease    [ 2,209 clinical trials,   1,276 drugs,   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways]
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,209 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03723447
(ClinicalTrials.gov)		October 23, 201826/10/2018Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®)A Prospective Randomized Trial of Transversus Abdominis Plane (TAP) INtraoperative Block With Bupivacaine/Dexamethasone aGainst Liposomal Bupivacaine (Exparel®): the TINGLE TrialPain, Postoperative;Crohn Disease;Inflammatory Bowel Diseases;Colorectal Cancer;Gastrointestinal Cancer;Gastrointestinal Disease;Digestive System Disease;Pain;Pain, Neuropathic;Intestinal DiseaseDrug: Liposomal bupivacaine;Drug: Bupivacaine/epinephrine/dexamethasoneCedars-Sinai Medical CenterNULLActive, not recruiting18 Years90 YearsAll100Phase 4United States